| Product Code: ETC9623486 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Lumasiran Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Lumasiran Market - Industry Life Cycle |
3.4 Taiwan Lumasiran Market - Porter's Five Forces |
3.5 Taiwan Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Taiwan Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Taiwan Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Taiwan Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Taiwan Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Taiwan Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Taiwan Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases like primary hyperoxaluria type 1 (PH1) in Taiwan |
4.2.2 Growing awareness among healthcare professionals and patients about RNA interference (RNAi) therapies |
4.2.3 Favorable government regulations and policies supporting the development and adoption of innovative treatments |
4.3 Market Restraints |
4.3.1 High cost associated with lumasiran treatment may limit accessibility for some patients |
4.3.2 Limited healthcare infrastructure and resources for managing rare diseases in Taiwan |
4.3.3 Competition from existing treatment options for PH1 patients |
5 Taiwan Lumasiran Market Trends |
6 Taiwan Lumasiran Market, By Types |
6.1 Taiwan Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Taiwan Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Taiwan Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Taiwan Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Taiwan Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Taiwan Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Taiwan Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Taiwan Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Taiwan Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Taiwan Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Taiwan Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Taiwan Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Taiwan Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Taiwan Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Taiwan Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Taiwan Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Taiwan Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Taiwan Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Taiwan Lumasiran Market Import-Export Trade Statistics |
7.1 Taiwan Lumasiran Market Export to Major Countries |
7.2 Taiwan Lumasiran Market Imports from Major Countries |
8 Taiwan Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for lumasiran in Taiwan |
8.2 Number of healthcare providers trained in administering lumasiran therapy |
8.3 Rate of reimbursement approval for lumasiran treatment by health insurance providers |
9 Taiwan Lumasiran Market - Opportunity Assessment |
9.1 Taiwan Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Taiwan Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Taiwan Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Taiwan Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Taiwan Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Taiwan Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Taiwan Lumasiran Market - Competitive Landscape |
10.1 Taiwan Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here